A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01224106
Recruitment Status : Active, not recruiting
First Posted : October 19, 2010
Last Update Posted : October 29, 2018
Information provided by (Responsible Party):
Hoffmann-La Roche